Join the club for FREE to access the whole archive and other member benefits.

Michel Sadelain

Immunologist and director at Center for Cell Engineering

Dr. Sadelain is founding director of the Center for Cell Engineering and head of the Gene Transfer and Gene Expression Laboratory at Memorial Sloan Kettering Cancer Center (MSKCC), where he holds the Stephen and Barbara Friedman Chair. He is also a member of the departments of medicine and pediatrics at Memorial Hospital and the molecular pharmacology and chemistry program of the Sloan Kettering Institute.

See also: Health Organisation Memorial Sloan Kettering Cancer Center - Cancer treatment and research institution in New York City

Details last updated 18-Jun-2020

Michel Sadelain News

2024 Breakthrough Prize honors medical innovations transforming lives

2024 Breakthrough Prize honors medical innovations transforming lives

Breakthrough Prize Foundation - 14-Sep-2023

Game-changing treatments for cancer, cystic fibrosis, and parkinson’s

Nature Biotechnology reviews the state of play of senolytics

Nature Biotechnology reviews the state of play of senolytics

Nature Biotechnology - 12-Nov-2020

In August, Unity announced that its lead drug candidate had failed to beat a placebo in reducing ...

Genetically engineered T cells can be used to target and kill senescent cells

Genetically engineered T cells can be used to target and kill senescent cells

Medical Xpress - 17-Jun-2020

Tested successfully in mice with liver fibrosis and lung cancer